Table 3. Neutralizing antibodies and the association with baseline data of 39 patients with chronic hepatitis C, genotype 1.

	DH6/JFH1	H77/JFH1	TN/JFH1	J4/JFH1	DH1/JFH1	DH5/JFH1
Male	982	65	60	51	42	63
Female	635	47	53	56	33	75
Intraveneous drug users	841	64	67	58	39	61
Non-IDU/unknown	869	56	53	50	39	70
BMI >25*	800	67	67	61	39	92
BMI ≤25*	993	57	50	48	39	48
Cirrhosis no**	768	52	61	48	35	59
Cirrhosis yes**	1089	86	86	79	50	147
Age ≤45	907	60	60	47	47	57
Age >45	841	58	57	55	36	71
HCV RNA ≥600.000	822	56	60	51	38	69
HCV RNA <600.000	939	65	56	53	40	62
ALT ≥70/100	678	50	59	50	36	61
ALT <70/100	1131	71	56	56	43	73

Geometric means of the NAb₅₀-titer of the different viruses compared to baseline variables.

^*Only 33 patients had a BMI calculated.

^**Only 26 patient had a biopsy taken.